The Pediatric Infectious Disease Journal · 2001 · 83 citations · 16 references
PharmacyPediatricsOutpatient Parenteral Antimicrobial TherapyPediatric Infectious DiseasesPediatric PharmacotherapyPediatric Adverse Drug ReactionsPediatric Antibiotic TherapyPediatric Antimicrobial TherapyPediatric Outpatient Parenteral Antimicrobial TherapyAntibiotic Adverse EffectsAntibiotic Prescribing In ChildrenAntibiotic-associated Adverse ReactionsOutpatient Antibiotic UseOutpatient Parenteral Antibiotic TherapyOutpatient Parenteral Antimicrobial Therapy ManagementPediatric Intravenous Antibiotic Therapy
Complications in children receiving outpatient parenteral antibiotic therapy were reviewed. Catheter-associated complications and/or adverse drug reactions occurred in 50% of courses. Most complications were minor, and almost all infections were successfully treated. Even with early discontinuation of parenteral antibiotics because of adverse drug reactions in 24% of the courses, the outcome was excellent. Outpatient parenteral antibiotic therapy (OPAT) can spare children the psychosocial impact of prolonged hospitalization and disruption of family interactions. Since the first reports of OPAT in the pediatric population, several articles on pediatric OPAT have been published. 1–20 Previously published reports on pediatric OPAT have included a relatively small number of patients (8 to 101), studied during a relatively short period (0.5 to 2 years), and often these reports had no follow-up post-OPAT. 2, 6, 8, 13, 18–20 The objective of this review was to evaluate complications associated with OPAT. Materials and methods. The records of patients who received OPAT under our care between January 1, 1995, and June 30, 1999, were retrospectively reviewed. All records were reviewed, and information was recorded using a data collection form and entered into an Excel database. Primary intravenous access was defined as the first catheter placed in the patient before starting OPAT. Rehospitalization was defined as a new hospital admission after OPAT was begun. Catheter-associated complications were defined as any mechanical and infectious complications associated with the catheters used for intravenous access for OPAT. Adverse drug reactions were any reactions deemed related to the antibiotics being used. Medical and social criteria used in the patient evaluation for OPAT could not be reviewed because of the retrospective nature of our analysis. It is our practice to have the family and the home situation evaluated before discharge for OPAT. Before discharge at least two family members were trained to administer intravenous antibiotics, about catheter management and how and what to look for in catheter-associated complications and adverse drug reactions. In addition initially a nurse visited the patient daily and then at least once a week while OPAT was administered. While receiving OPAT patients were seen at least once every week or every other week, and weekly laboratory tests were done. Results. A total of 229 patients with a mean age of 8 years (median, 8 years; range, 14 days to 19 years) received 237 courses of OPAT. The majority of patients were male [127 (55%)] and Caucasian [170 (74%)]. The infections treated with OPAT are listed in Table 1. During the review period OPAT use increased by almost 4-fold, from 21 courses in 1995 to 40 courses in the first 6 months of 1999 (annualized for 1999 = 80). The fastest growing age group during the study period were patients ≤2 years of age, showing a 7-fold increase, from 1 (5%) of 21 patient in 1995 to 14 (35%) of 40 patients in the first 6 months of 1999 (annualized for 1999 = 28 of 80). A total of 42 (18%) patients ≤1 year of age and 1 (0.4%) ≤1 month of age received OPAT during the study period. The average post-OPAT follow-up period was 8 weeks (range, 1 to 67 weeks).Table 1: Distribution of infections treated with OPATPrimary intravenous access included central venous catheters for 125 (53%) courses, peripherally inserted central catheters for 99 (42%), peripheral intravenous catheters for 7 (3%) and unknown for 6 (2%) courses. Central venous catheters represented at least 50% of the catheters used during each year of the review period except in the year 1998 (34%). The use of peripherally inserted central catheters increased from 33% in 1995 to 59% in 1998. During the first 6 months of 1999, 45% of catheters were peripherally inserted central catheters. For all age groups catheter types were equally distributed between central venous catheters and peripherally inserted central catheters except among patients ≤2 years of age in whom central venous catheters were placed in 65% courses and peripherally inserted central catheters in 28%. The average time to developing catheter-associated complications was 22 days (range, 1 to 81 days). The overall rate of catheter-associated complications (per 100 days of OPAT) was one and involved 29% of all patients receiving OPAT. There were a total of 74 catheter-associated complications in 69 (29%) OPAT courses. Catheter-associated complications prompted cessation of OPAT in 17 (7%) courses. A total of 289 catheters were used during 237 OPAT courses. The mean life for all catheter types was 19.5 days (range, 1 to 64 days). The mean life was 14 days (range, 6 to 64 days) for peripherally inserted central catheters and 24 days (range, 1 to24 days) for central venous catheters. The OPAT was completed with 1, 2, 3 and 4 catheters in 194 (82%), 36 (15%), 5 (2%) and 2 (1%) courses, respectively. A catheter was replaced at least once in 43 (18%) OPAT courses. Adverse drug reactions developed in 70 (29%) OPAT courses and prompted early discontinuation of antibiotics in 58 (24%). Both adverse drug reactions and catheter associated complications developed in 20 (8%) OPAT courses. In some OPAT courses adverse drug reactions occurred to more than one antibiotic. One third of adverse drug reactions developed during nafcillin use, the most common being neutropenia. Average time to adverse drug reactions was 19 days (range 1–71 days). The overall rate of adverse drug reactions (number of events per 100 days of antibiotic use) was 1.1 (range: 0.6 in ceftriaxone and vancomycin to 5.2 in oxacillin) and occurred in 30% of patients receiving OPAT. Neutropenia and rash each had an overall rate of 0.4. Neutropenia occurred in 13% and rash in 12% of patients receiving OPAT. The average time to the development of neutropenia and rash was 20 and 17 days, respectively. Cefotaxime had the highest rate of neutropenia at 1.6 occurring in 33% of patients receiving cefotaxime. Oxacillin use had the highest rate of both rash (2.4) and hepatitis (1.4). Forty-three percent of patients receiving oxacillin developed rash and 27% developed hepatitis. The overall rate of hepatitis for all antibiotics used was 0.1 and occurred in 5% of patients receiving OPAT. The average time to development of hepatitis was 21 days. One-third of all adverse drug reactions developed with oxacillin use, and overall the most common adverse drug reaction was rash. Other adverse drug reactions (diarrhea, fever, urticaria, anaphylaxis, ototoxicity) combined had an overall rate of 0.2 and involved 4% of patients receiving OPAT. Rehospitalization was necessary during 62 (26%) OPAT courses. Catheter-associated complications and catheter changes prompted rehospitalization in 26 (42%) courses, adverse drug reactions in 17 (27%), surgery for treatment of primary disease in 18 (29%) and various other causes in 5 (8%). A few patients were rehospitalized more than once or had more than one reason for rehospitalization. Discussion. Although large retrospective reviews in adults receiving OPAT have been published, 21, 22 reports of large number of pediatric patients are lacking. 1–20 This review represents the report of the largest number of children studied, for the longest period and for a longer post-OPAT follow-up period than any previous study of pediatric patients. This allowed us to determine complications and outcome of OPAT. The use of OPAT increased almost 4-fold during the study period. Even though many different types of infections were treated with OPAT, musculoskeletal infections remained the most commonly treated infection. The mean duration of therapy (31 days) in our review was longer than the duration of therapy in other OPAT studies in children. 1–6, 9, 18, 19 This longer duration of therapy allowed us to evaluate the development of OPAT complications that would not have developed in shorter courses of antibiotic therapy. The average time to develop catheter-associated complications and adverse drug reactions was similar to that in adult patients. 23 The use of peripherally inserted central catheters and central venous catheters that last longer than peripherally intravenous catheters is convenient, and it avoids the need for frequent scheduled and unscheduled catheter changes. 2, 9 Central venous catheters and peripherally inserted central catheters had higher complication rates (25 and 38%, respectively) than those previously reported in studies in adult patients. 22 Based on our review, in OPAT courses with a predicted duration of >14 days, the use of central venous catheters might need to be considered. However, the safety of placing peripherally inserted central catheters compared with central venous catheters (general anesthesia, use of operating room, etc.) should favor the selection of peripherally inserted central catheters as primary vascular access for OPAT. Adverse drug reactions are expected events of OPAT as indeed they are during the hospital therapy. Both rash (12%vs. 5%) and neutropenia (13%vs. 7%) occurred more frequently in children than in adults receiving OPAT. 22 In our experience hepatitis was most common with the use of oxacillin. 15 This was noticed after change of hospital formulary from nafcillin to oxacillin. We have since reinstated nafcillin treatment and seen a decrease in drug-associated hepatitis, and we recommend that nafcillin be used instead of oxacillin. If oxacillin is used, close monitoring of liver function is advisable. There were no cases of anaphylaxis, pseudomembrane colitis, Clostridium difficile-associated diarrhea or colitis or ceftriaxone-related sludging in the gallbladder. Rehospitalization rates were higher in our patients than in adult patients (27%vs. 8%). 21, 22 If hospitalization for peripherally inserted central catheter replacement were excluded, the rates were still higher for children (19%vs. 8%). A peripherally inserted central catheter replacement is a preventable cause of rehospitalization for most children and can be done on an outpatient basis. In our experience 99% of the infections resolved with full recovery in patients receiving OPAT. This rate is similar to those previously reported in studies of pediatric and adult patients reaffirming the success of OPAT. 2, 6, 8, 21 Quality of life issues during OPAT could not be addressed in this retrospective analysis. Further studies are needed to gain insight into the impact of OPAT on patients’ and families’ lives. In addition a more detailed analysis of complications, psychosocial impact of OPAT and issues such as infection control must be done. Increased use of OPAT is a trend in the management of pediatric infections that will continue to increase. A significant number of infections can now conveniently, safely and effectively be treated at home. Close monitoring of potential complications is needed. Medical and social criteria must apply when identifying suitable candidates. Pediatric guidelines for OPAT similar to adult guidelines need to be established. These guidelines could be easily adapted from adult guidelines with some modifications and with special attention to the patient’s age, type of catheter used and monitoring for adverse drug reactions and catheter-associated complications.
16
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients
Craig A. Mullen, Demetrios Petropoulos, Walter Roberts et al. · Cancer · 1999 · 155 citations · Full text
Medicine, Oncology, Pediatrics +11
Adverse effects of outpatient parenteral antibiotic therapy
MargaretL Hoffman-Terry, HenryS Fraimow, TimothyR Fox et al. · The American Journal of Medicine · 1999 · 115 citations
Practice Guidelines for Community‐Based Parenteral Anti‐Infective Therapy
David N. Williams, Susan J. Rehm, Alan D. Tice et al. · Clinical Infectious Diseases · 1997 · 113 citations · Full text